|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2300 AUD | 0.00% |
|
-4.17% | -31.34% |
| 06-09 | Compumedics Limited Announces Appointment of Mike Stone as Chief Commercial Officer for Its US Operations | CI |
| 04-20 | Compumedics Sees Fiscal Year 2026 EBITDA of Up to AU$7 Million | MT |
Company Valuation: Compumedics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 69.98 | 59.35 | 48.97 | 45.95 | - | - |
| Change | - | - | -17.49% | -6.18% | - | - |
| Enterprise Value (EV) | 69.98 | 59.35 | 48.97 | 45.95 | 45.95 | 45.95 |
| Change | - | - | -17.49% | -6.18% | 0% | 0% |
| P/E | 65.8x | -335x | -36.4x | 15.3x | 6.22x | 4.51x |
| PBR | - | - | - | - | - | - |
| PEG | - | - | -0x | -0x | 0x | 0.1x |
| Capitalization / Revenue | 1.96x | - | 0.96x | 0.69x | 0.58x | 0.48x |
| EV / Revenue | 0x | - | 0x | 0.69x | 0.58x | 0.48x |
| EV / EBITDA | 0x | - | 0x | 6.38x | 3.45x | 2.64x |
| EV / EBIT | 0x | - | 0x | 9.57x | 4.22x | 3.1x |
| EV / FCF | -0x | - | -0x | 30.6x | 8.84x | 6.05x |
| FCF Yield | -0.33% | - | -13.7% | 3.26% | 11.3% | 16.5% |
| Dividend per Share 2 | - | - | - | - | 0.02 | 0.028 |
| Rate of return | - | - | - | - | 8.7% | 12.2% |
| EPS 2 | 0.006 | -0.001 | -0.007 | 0.015 | 0.037 | 0.051 |
| Distribution rate | - | - | - | - | 54.1% | 54.9% |
| Net sales 1 | 35.74 | - | 50.96 | 66.3 | 79.7 | 95.2 |
| EBITDA 1 | 2.563 | - | 2.938 | 7.2 | 13.3 | 17.4 |
| EBIT 1 | 1.106 | - | 0.692 | 4.8 | 10.9 | 14.8 |
| Net income 1 | 0.998 | -0.499 | -1.272 | 3.8 | 9 | 12.8 |
| Net Debt | - | - | - | - | - | - |
| Reference price 2 | 0.3950 | 0.3350 | 0.2550 | 0.2300 | 0.2300 | 0.2300 |
| Nbr of stocks (in thousands) | 177,163 | 177,163 | 192,039 | 199,762 | - | - |
| Announcement Date | 8/26/21 | 8/30/24 | 8/26/25 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 15.33x | - | - | -.--% | 31.96M | |
| 26.39x | 4.75x | 18.29x | 0.35% | 196B | |
| 44.98x | 11.7x | 26.18x | -.--% | 144B | |
| 32.21x | - | - | 0.72% | 141B | |
| 16.45x | 3.42x | 11x | -.--% | 66.54B | |
| 32.88x | 7.35x | 23.38x | -.--% | 53.09B | |
| 18.34x | 2.12x | 10.96x | 2.86% | 44.12B | |
| 26.09x | 5.2x | 17.77x | 0.76% | 37.93B | |
| 45.62x | 6.37x | 19.56x | -.--% | 36.96B | |
| 14.53x | 1.62x | 9.08x | 0.24% | 29.43B | |
| Average | 27.28x | 5.31x | 17.03x | 0.49% | 74.89B | |
| Weighted average by Cap. | 30.63x | 6.26x | 18.87x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CMP Stock
- Valuation Compumedics Limited
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
